Bend OR 肺动脉高压临床试验
6项针对 肺动脉高压的研究正在 Bend及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
An Open-Label Extension Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
招募中3 期
- USA003, Bend
Efficacy and Safety Study of Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
招募中3 期
- USA003, Bend
A Phase 3 Study to Evaluate the Safety and Efficacy L606 in Participants With PH-ILD
招募中3 期
- Summit Health, Bend
A Study of ROC-101 in Patients With Pulmonary Arterial Hypertension (PAH) and Pulmonary Hypertension Associated With Interstitial Lung Disease (ILD-PH) (ROCSTAR STUDY)
招募中2 期
- Bend Memorial Clinic, Bend
A Phase 3 Trial of Inhaled Mosliciguat in PH-ILD (PHrontier)
招募中3 期
- Clinical Research Site, Bend
DeciPHer-ILD: A Real-world Patient Registry in Group 3 Pulmonary Hypertension Associated With Interstitial Lung Disease (PH-ILD)
招募中观察性研究
- Summit Health, Bend
其他城市的 肺动脉高压试验
- Philadelphia, PA11 项研究
- Aurora, CO9 项研究
- Boston, MA8 项研究
- Kansas City, KS8 项研究
- Cincinnati, OH8 项研究
- New York City, NY8 项研究
- Rochester, MN7 项研究
- Salt Lake City, UT7 项研究
- Washington, DC7 项研究
- Charleston, SC7 项研究
- Houston, TX7 项研究
- Indianapolis, IN7 项研究
Bend的其他研究
数据来自 ClinicalTrials.gov，检索日期：2026年11月15日。每项研究自行设定入选标准，由研究团队决定谁能参与。